|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
CardioDx, Inc. to Present at JMP Securities Healthcare Conference
7/9/2012 11:10:12 AM
PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced its participation at the JMP Securities Healthcare Conference to be held July 12-13 in New York. Mark Monane, M.D., the company’s chief medical officer, will provide an overview of CardioDx and of Corus® CAD, the first and only clinically validated gene expression test for obstructive coronary artery disease. The presentation will take place on Thursday, July 12 at 9:30 a.m. ET at the Peninsula Hotel.
|
|
|
|
|
|
|
|
|
|
|